Search Login Register

Glucagonoma Summary

308 relevant articles (8 outcomes, 16 trials/studies) found for this Disease

Description: An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.

Also Known As: Adenoma, alpha Cell; Adenomas, alpha-Cell; Glucagonomas; Tumor, alpha-Cell; Tumors, alpha-Cell Show All >>

Key Drugs and Agents for Glucagonoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Octreotide (Sandostatin) : 5 outcomes 2 studies in 34 results : FDA 13 Generic
  2. Glucagon (Glukagon) : 2 outcomes 3 studies in 117 results : FDA 4
  3. Somatostatin (Somatotropin Release-Inhibiting Factor) : 1 outcome 2 studies in 28 results : IBA
  4. Messenger RNA (mRNA) : 1 outcome 1 study in 10 results : IBA
  5. Amino Acids : 1 outcome 1 study in 6 results : FDA 53
  6. Hormones : 1 outcome in 20 results : IBA
  7. Dacarbazine (DIC) : 1 outcome in 9 results : FDA 10 Generic
  8. Gastrins : 1 outcome in 8 results : IBA
  9. Insulin (Novolin) : 1 study in 27 results : FDA 2
  10. Pancreatic Polypeptide (Pancreatic Polypeptide (PP)) : 1 study in 17 results : IBA
Show All >>

Diseases Related to Glucagonoma

  1. Neoplasms (Cancer)
  2. Syndrome
  3. Gastrinoma
  4. Carcinoid Tumor (Carcinoid)
  5. Neoplasm Metastasis (Metastasis)
Show All >>

Key Therapies for Glucagonoma

Efficacy Chart >>
  1. Pancreatectomy : 1 study in 6 results
  2. Therapeutics : 1 study in 1 result
  3. Drug Therapy (Chemotherapy) : 7 results
  4. Transplants (Transplant) : 3 results
  5. Liver Transplantation : 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.